The trial will begin in January 2020 and will be led by Charles Czeisler, MD, PhD, a senior physician in the Brigham and Women’s division of sleep and circadian disorders and the Baldino professor of sleep medicine at Harvard Medical School. Dr. Czeisler’s team will monitor hospital employees’ use of the Dayzz sleep app, which is currently available to U.S. employers and provides workers with personalized sleep training plans.
“Sleep deficiency is a hidden cost of our tech-driven, 24/7 society. Our goal is to help a representative workforce population working within a large corporation get more, higher-quality sleep, which we expect will lead to increased productivity, mood, alertness and energy, while decreasing sick days and healthcare costs over the nine-month follow up period,” Mairav Cohen-Zion, PhD, Dayzz’s chief science officer, said in a news release.
More articles on health IT:
Nebraska health system transitions to Epic EHR
Rutgers, Microsoft develop mobile app to reduce SIDS risk
9 HIPAA settlements of 2019
